Britain approves the use of an anti-Corona drug 

Britain has approved the use of an anti-Corona drug produced by Pfizer for patients over the age of 18, with mild to moderate symptoms and at risk of a worsening of their disease. 

The Medicines and Healthcare products Regulatory Agency in Britain said that "Paxlovid" tablets are more effective when taken during the early stages of infection. 

Britain also recommended using the medication within five days of the onset of symptoms. 

“Pfizer” company announced earlier this month that “Paxilovide” showed an effectiveness of up to 90%, in reducing hospital admissions and deaths for patients at high risk, and recent laboratory studies indicate that the drug retains its effectiveness in the face of the mutant. Omicron is rapidly spreading. 

Britain's approval of the drug came at a time when the country is seeking to confront the record rise in daily cases of corona in the winter, amid the rapid spread of the "Omicron" mutant.